MORGAN STANLEY PLC/CALL/SANOFI/89/0.1/20.12.24 Share Price

Warrant

DE000MB313X3

Market Closed - Börse Stuttgart 07:25:16 01/07/2024 BST
0.74 EUR +1.37% Intraday chart for MORGAN STANLEY PLC/CALL/SANOFI/89/0.1/20.12.24
Current month+5.80%
1 month+4.29%
Date Price Change
01/07/24 0.74 +1.37%
28/06/24 0.73 +7.35%
27/06/24 0.68 -11.69%
26/06/24 0.77 -8.33%
25/06/24 0.84 +12.00%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 07:25 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
Issuer Morgan Stanley
WKN MB313X
ISINDE000MB313X3
Date issued 31/01/2023
Strike 89
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 1.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.03
Lowest since issue 0.4

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.94 EUR
Average target price
107.9 EUR
Spread / Average Target
+19.93%
Consensus